Person

Thomas J. Lynch, Jr.

Formerly EVP & Chief Scientific Officer · Director, Bristol Myers Squibb

Current S&P 500 boards
0
Current roles
0
Open-market buys
$0
Open-market sales
$335K

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Dec 12, 2017BMYSale5,300$63.24$335K

SEC reporting-owner ID (CIK) 1474056 · all filings on EDGAR